Search Results

There are 63840 results for: content related to: Hemorrhagic events in hepatocellular carcinoma patients treated with antiangiogenic therapies

  1. Clinical outcome of sorafenib treatment in patients with advanced hepatocellular carcinoma refractory to hepatic arterial infusion chemotherapy

    Journal of Gastroenterology and Hepatology

    Volume 28, Issue 12, December 2013, Pages: 1834–1841, Daisuke Miyaki, Hiroshi Aikata, Hiromi Kan, Hatsue Fujino, Ayako Urabe, Keiichi Masaki, Takayuki Fukuhara, Tomoki Kobayashi, Noriaki Naeshiro, Takashi Nakahara, Tomokazu Kawaoka, Akira Hiramatsu, Shoichi Takahashi, Masaki Ishikawa, Hideaki Kakizawa, Kazuo Awai and Kazuaki Chayama

    Version of Record online : 22 NOV 2013, DOI: 10.1111/jgh.12311

  2. You have free access to this content
    Treating advanced hepatocellular carcinoma: How to get out of first gear

    Cancer

    Volume 120, Issue 20, October 15, 2014, Pages: 3122–3130, James J. Harding and Ghassan K. Abou-Alfa

    Version of Record online : 4 JUN 2014, DOI: 10.1002/cncr.28850

  3. You have free access to this content
    Poster Session 1: Cellular Immunobiology, Preservation, and Cell Transplantation in Transplant; Clinical: Hepatocellular Carcinoma and Cholangiocarcinoma

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 380A–456A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28212

  4. You have free access to this content
    A new patient-focused approach to the treatment of metastatic renal cell carcinoma: establishing customized treatment options

    BJU International

    Volume 107, Issue 8, April 2011, Pages: 1190–1199, Joaquim Bellmunt, Tim Eisen, Cezary Szczylik, Peter Mulders and Camillo Porta

    Version of Record online : 15 NOV 2010, DOI: 10.1111/j.1464-410X.2010.09829.x

  5. MicroRNA-425-3p predicts response to sorafenib therapy in patients with hepatocellular carcinoma

    Liver International

    Volume 35, Issue 3, March 2015, Pages: 1077–1086, Valentina Vaira, Massimo Roncalli, Carlo Carnaghi, Alice Faversani, Marco Maggioni, Claudia Augello, Lorenza Rimassa, Tiziana Pressiani, Gaia Spagnuolo, Luca Di Tommaso, Stefano Fagiuoli, Elena Rota Caremoli, Massimo Barberis, Roberto Labianca, Armando Santoro and Silvano Bosari

    Version of Record online : 20 JUL 2014, DOI: 10.1111/liv.12636

  6. You have free access to this content
    Differential effects of sorafenib on liver versus tumor fibrosis mediated by stromal-derived factor 1 alpha/C-X-C receptor type 4 axis and myeloid differentiation antigen–positive myeloid cell infiltration in mice

    Hepatology

    Volume 59, Issue 4, April 2014, Pages: 1435–1447, Yunching Chen, Yuhui Huang, Thomas Reiberger, Annique M. Duyverman, Peigen Huang, Rekha Samuel, Lotte Hiddingh, Sylvie Roberge, Christina Koppel, Gregory Y. Lauwers, Andrew X. Zhu, Rakesh K. Jain and Dan G. Duda

    Version of Record online : 18 FEB 2014, DOI: 10.1002/hep.26790

  7. You have free access to this content
    New molecularly targeted therapies against advanced hepatocellular carcinoma: From molecular pathogenesis to clinical trials and future directions

    Hepatology Research

    Volume 45, Issue 10, October 2015, Pages: E1–E11, Makoto Chuma, Katsumi Terashita and Naoya Sakamoto

    Version of Record online : 9 JAN 2015, DOI: 10.1111/hepr.12459

  8. You have free access to this content
    Incidence and Risk of Sorafenib-Induced Hypertension: A Systematic Review and Meta-Analysis

    The Journal of Clinical Hypertension

    Volume 16, Issue 3, March 2014, Pages: 177–185, Yan Li, Shun Li, Yaofeng Zhu, Xinyue Liang, Hui Meng, Jun Chen, Dongqing Zhang, Hu Guo and Benkang Shi

    Version of Record online : 12 MAR 2014, DOI: 10.1111/jch.12273

  9. You have free access to this content
    Sorafenib relieves cell-intrinsic and cell-extrinsic inhibitions of effector T cells in tumor microenvironment to augment antitumor immunity

    International Journal of Cancer

    Volume 134, Issue 2, 15 January 2014, Pages: 319–331, Mei-Ling Chen, Bo-Shiun Yan, Wan-Chih Lu, Mei-Huei Chen, Sung-Liang Yu, Pan-Chyr Yang and Ann-Lii Cheng

    Version of Record online : 30 JUL 2013, DOI: 10.1002/ijc.28362

  10. Characteristics of 18 patients with hepatocellular carcinoma who obtained a complete response after treatment with sorafenib

    Hepatology Research

    Volume 44, Issue 13, December 2014, Pages: 1268–1276, Satoshi Shiba, Takuji Okusaka, Masafumi Ikeda, Hidetsugu Saito and Takafumi Ichida

    Version of Record online : 18 FEB 2014, DOI: 10.1111/hepr.12297

  11. Guideline on the use of new anticancer drugs for the treatment of Hepatocellular Carcinoma 2010 update

    Hepatology Research

    Volume 42, Issue 6, June 2012, Pages: 523–542, Shuichi Kaneko, Junji Furuse, Masatoshi Kudo, Kenji Ikeda, Masao Honda, Yasunari Nakamoto, Morikazu Onchi, Goshi Shiota, Osamu Yokosuka, Isao Sakaida, Tetsuo Takehara, Yoshiyuki Ueno, Kazumasa Hiroishi, Shuhei Nishiguchi, Hisataka Moriwaki, Kazuhide Yamamoto, Michio Sata, Shuntaro Obi, Shiro Miyayama and Yukinori Imai

    Version of Record online : 8 MAY 2012, DOI: 10.1111/j.1872-034X.2012.00981.x

  12. Effect of treatment with branched-chain amino acids during sorafenib therapy for unresectable hepatocellular carcinoma

    Hepatology Research

    Volume 44, Issue 3, March 2014, Pages: 302–312, Haruhiko Takeda, Hiroki Nishikawa, Eriko Iguchi, Yoshiaki Ohara, Azusa Sakamoto, Sumio Saito, Norihiro Nishijima, Akihiro Nasu, Hideyuki Komekado, Ryuichi Kita, Toru Kimura and Yukio Osaki

    Version of Record online : 29 APR 2013, DOI: 10.1111/hepr.12125

  13. You have free access to this content
    CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice

    Hepatology

    Volume 61, Issue 5, May 2015, Pages: 1591–1602, Yunching Chen, Rakesh R. Ramjiawan, Thomas Reiberger, Mei R. Ng, Tai Hato, Yuhui Huang, Hiroki Ochiai, Shuji Kitahara, Elizabeth C. Unan, Tejaswini P. Reddy, Christopher Fan, Peigen Huang, Nabeel Bardeesy, Andrew X. Zhu, Rakesh K. Jain and Dan G. Duda

    Version of Record online : 20 MAR 2015, DOI: 10.1002/hep.27665

  14. You have free access to this content
    Inhibition of doxorubicin-induced autophagy in hepatocellular carcinoma Hep3B cells by sorafenib – the role of extracellular signal-regulated kinase counteraction

    The FEBS Journal

    Volume 278, Issue 18, September 2011, Pages: 3494–3507, Irena Manov, Yulia Pollak, Rinata Broneshter and Theodore C. Iancu

    Version of Record online : 5 SEP 2011, DOI: 10.1111/j.1742-4658.2011.08271.x

  15. You have free access to this content
    Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma

    International Journal of Cancer

    Volume 131, Issue 3, 1 August 2012, Pages: 548–557, Satoshi Shimizu, Tetsuo Takehara, Hayato Hikita, Takahiro Kodama, Hinako Tsunematsu, Takuya Miyagi, Atsushi Hosui, Hisashi Ishida, Tomohide Tatsumi, Tatsuya Kanto, Naoki Hiramatsu, Naonobu Fujita, Tamotsu Yoshimori and Norio Hayashi

    Version of Record online : 12 SEP 2011, DOI: 10.1002/ijc.26374

  16. Sorafenib sensitizes hepatocellular carcinoma cells to physiological apoptotic stimuli

    Journal of Cellular Physiology

    Volume 227, Issue 4, April 2012, Pages: 1319–1325, Joan Fernando, Patricia Sancho, Conrado M. Fernández-Rodriguez, José L. Lledó, Laia Caja, Jean S. Campbell, Nelson Fausto and Isabel Fabregat

    Version of Record online : 11 JAN 2012, DOI: 10.1002/jcp.22843

  17. You have free access to this content
    Nuclear factor kappa B–mediated CD47 up-regulation promotes sorafenib resistance and its blockade synergizes the effect of sorafenib in hepatocellular carcinoma in mice

    Hepatology

    Volume 62, Issue 2, August 2015, Pages: 534–545, Jessica Lo, Eunice Yuen Ting Lau, Rachel Hiu Ha Ching, Bowie Yik Ling Cheng, Mark Kin Fai Ma, Irene Oi Lin Ng and Terence Kin Wah Lee

    Version of Record online : 3 JUN 2015, DOI: 10.1002/hep.27859

  18. You have free access to this content
    The combination of transcatheter arterial chemoembolization and sorafenib is well tolerated and effective in Asian patients with hepatocellular carcinoma: Final results of the START trial

    International Journal of Cancer

    Volume 136, Issue 6, 15 March 2015, Pages: 1458–1467, Yee Chao, Young-Hwa Chung, Guohong Han, Jung-Hwan Yoon, Jijin Yang, Jianhua Wang, Guo-Liang Shao, Byung Ik Kim and Teng-Yu Lee

    Version of Record online : 16 SEP 2014, DOI: 10.1002/ijc.29126

  19. You have free access to this content
    EGFR activation is a potential determinant of primary resistance of hepatocellular carcinoma cells to sorafenib

    International Journal of Cancer

    Volume 131, Issue 12, 15 December 2012, Pages: 2961–2969, Zakaria Ezzoukhry, Christophe Louandre, Eric Trécherel, Corinne Godin, Bruno Chauffert, Sébastien Dupont, Momar Diouf, Jean-Claude Barbare, Jean-Claude Mazière and Antoine Galmiche

    Version of Record online : 30 APR 2012, DOI: 10.1002/ijc.27604

  20. Comparison of hepatic arterial infusion chemotherapy versus sorafenib monotherapy in patients with advanced hepatocellular carcinoma

    Journal of Digestive Diseases

    Volume 16, Issue 9, September 2015, Pages: 505–512, Tomokazu Kawaoka, Hiroshi Aikata, Hideyuki Hyogo, Reona Morio, Kei Morio, Masahiro Hatooka, Takayuki Fukuhara, Tomoki Kobayashi, Noriaki Naeshiro, Daisuke Miyaki, Akira Hiramatsu, Michio Imamura, Yoshiiku Kawakami, Shoichi Takahashi, Koji Waki, Keiji Tsuji, Hirotaka Kohno, Hiroshi Kohno, Takashi Moriya and Kazuaki Chayama

    Version of Record online : 28 SEP 2015, DOI: 10.1111/1751-2980.12267